The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives

Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis

(2010) A.-M. TOBIN et al.   JOURNAL OF RHEUMATOLOGY

Excessive Body Weight and Smoking Associates with a High Risk of Onset of Plaque Psoriasis

(2009) K Wolk et al.   ACTA DERMATO-VENEREOLOGICA

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

(2009) C.H. Smith et al.   BRITISH JOURNAL OF DERMATOLOGY

National Registries of Systemic Treatment for Psoriasis and the European ‘Psonet’ Initiative

(2008) L.L.A. Lecluse et al.   DERMATOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2008) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET